PL3226854T3 - Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry - Google Patents

Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry

Info

Publication number
PL3226854T3
PL3226854T3 PL15825820T PL15825820T PL3226854T3 PL 3226854 T3 PL3226854 T3 PL 3226854T3 PL 15825820 T PL15825820 T PL 15825820T PL 15825820 T PL15825820 T PL 15825820T PL 3226854 T3 PL3226854 T3 PL 3226854T3
Authority
PL
Poland
Prior art keywords
fibroelastin
reconstruction
skin
amino acids
connective tissue
Prior art date
Application number
PL15825820T
Other languages
English (en)
Inventor
Paolo Giorgetti
Original Assignee
Professional Dietetics International S.r.l. in forma abbreviata P.D. INT. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics International S.r.l. in forma abbreviata P.D. INT. S.R.L. filed Critical Professional Dietetics International S.r.l. in forma abbreviata P.D. INT. S.R.L.
Publication of PL3226854T3 publication Critical patent/PL3226854T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15825820T 2014-12-04 2015-12-03 Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry PL3226854T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20142084 2014-12-04
PCT/IB2015/059330 WO2016088078A1 (en) 2014-12-04 2015-12-03 Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
EP15825820.2A EP3226854B1 (en) 2014-12-04 2015-12-03 Aminoacid-based composition for fibroelastin recovery in dermal connective tissues

Publications (1)

Publication Number Publication Date
PL3226854T3 true PL3226854T3 (pl) 2020-08-24

Family

ID=52463041

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15825820T PL3226854T3 (pl) 2014-12-04 2015-12-03 Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry

Country Status (22)

Country Link
US (1) US10272059B2 (pl)
EP (1) EP3226854B1 (pl)
JP (1) JP6726182B2 (pl)
KR (1) KR102429451B1 (pl)
CN (2) CN121695132A (pl)
AU (1) AU2015356587B2 (pl)
BR (1) BR112017011476B1 (pl)
CA (1) CA2969383C (pl)
CY (1) CY1123040T1 (pl)
DK (1) DK3226854T3 (pl)
ES (1) ES2777775T3 (pl)
LT (1) LT3226854T (pl)
MX (1) MX368900B (pl)
MY (1) MY185991A (pl)
PH (1) PH12017501003B1 (pl)
PL (1) PL3226854T3 (pl)
RS (1) RS60268B1 (pl)
RU (1) RU2704032C2 (pl)
SA (1) SA517381725B1 (pl)
SG (1) SG11201704423SA (pl)
UA (1) UA120627C2 (pl)
WO (1) WO2016088078A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IT201700075026A1 (it) * 2017-07-04 2019-01-04 Professional Derma Sa Composizioni iniettabili per filler dermico
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
KR102226810B1 (ko) * 2020-09-02 2021-03-15 주식회사 엘라스틱랩 연결 조직 중 엘라스틴 및 콜라겐 생합성 증진용 조성물
US20230148647A1 (en) * 2020-09-02 2023-05-18 Elastic Lab Inc. Composition for promoting biosynthesis of elastin and collagen in connective tissue
IT202100023903A1 (it) * 2021-09-16 2023-03-16 Professional Derma Sa Composizione ad uso cosmetico
CN115670969B (zh) * 2022-11-08 2023-11-07 瑞玞生物医学(深圳)有限公司 一种刺激弹性蛋白形成的组合物
IT202300009351A1 (it) * 2023-05-10 2024-11-10 Professional Dietetics Spa Composizioni comprendenti acido ialuronico, aminoacidi e intermedi del ciclo di krebs utili per aumentare l'espressione genica della matrice extracellulare
IT202400002641A1 (it) 2024-02-08 2025-08-08 Professional Dietetics Spa Uso di miscele di amminoacidi e acido ialuronico per il trattamento di senescenza cellulare
FR3167543A1 (fr) 2024-10-18 2026-04-24 Nutrizoe Formulation comprenant un ou plusieurs acide(s) aminé(s)
WO2026082896A1 (fr) 2024-10-18 2026-04-23 Nutrizoe Formulation comprenant un ou plusieurs acide(s) aminé(s)
WO2026087731A1 (en) 2024-10-25 2026-04-30 Intibio Bv Pharmaceutical composition comprising an amino acid composition in purified hyaluronic acid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE226433T1 (de) * 1992-12-22 2002-11-15 Baxter Int Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse
JP3553992B2 (ja) * 1993-05-28 2004-08-11 独立行政法人理化学研究所 代謝調節剤
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
CN1126541C (zh) * 1999-12-03 2003-11-05 中国人民解放军军事医学科学院放射医学研究所 新型复合氨基酸组合物
JP2004123564A (ja) * 2002-09-30 2004-04-22 Inst Of Physical & Chemical Res 中枢機能改善用アミノ酸組成物
FR2849383B1 (fr) 2002-12-26 2005-09-30 Jean Noel Thorel Composition trophique en milieu aqueux, et ses applications, notamment en ophtalmologie
DE10313200A1 (de) 2003-03-19 2004-10-07 Ami-Agrolinz Melamine International Gmbh Prepregs für Faserverbunde hoher Festigkeit und Elastizität
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
US20080102107A1 (en) 2005-12-16 2008-05-01 Valex Pharmaceuticals, Llc Compositions and methods for transdermal joint pain therapy
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
CN102131492B (zh) * 2008-08-27 2013-04-24 株式会社太平洋 含胶原肽的皮肤美容用组合物
FR2948286B1 (fr) * 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
EA201001104A1 (ru) * 2010-07-29 2011-04-29 Елена Михайловна Хороших Препарат и способ профилактики и коррекции патологических состояний животных на его основе
CN104013619A (zh) * 2014-05-27 2014-09-03 刘力 复方氨基酸注射液18aa-v的药物组合物和用途

Also Published As

Publication number Publication date
WO2016088078A1 (en) 2016-06-09
CA2969383A1 (en) 2016-06-09
EP3226854A1 (en) 2017-10-11
RU2704032C2 (ru) 2019-10-23
AU2015356587A1 (en) 2017-06-29
MX2017007184A (es) 2017-12-04
MY185991A (en) 2021-06-14
PH12017501003B1 (en) 2022-01-21
UA120627C2 (uk) 2020-01-10
EP3226854B1 (en) 2020-02-26
BR112017011476A2 (pt) 2018-02-27
CA2969383C (en) 2023-05-09
CN106999390A (zh) 2017-08-01
MX368900B (es) 2019-10-21
US20170326089A1 (en) 2017-11-16
RU2017118971A3 (pl) 2019-05-31
KR20170088868A (ko) 2017-08-02
RU2017118971A (ru) 2019-01-10
CN121695132A (zh) 2026-03-20
AU2015356587B2 (en) 2020-04-09
JP2017536388A (ja) 2017-12-07
BR112017011476B1 (pt) 2023-02-23
US10272059B2 (en) 2019-04-30
CY1123040T1 (el) 2021-10-29
ES2777775T3 (es) 2020-08-06
SA517381725B1 (ar) 2021-04-12
PH12017501003A1 (en) 2017-12-18
DK3226854T3 (da) 2020-03-23
SG11201704423SA (en) 2017-06-29
RS60268B1 (sr) 2020-06-30
NZ732377A (en) 2023-12-22
LT3226854T (lt) 2020-04-27
KR102429451B1 (ko) 2022-08-04
JP6726182B2 (ja) 2020-07-22

Similar Documents

Publication Publication Date Title
BR112016026378A2 (pt) formulações e métodos para tratamento com queratina
PT3185957T (pt) Patisiran para utilização no tratamento de amoloidose mediada por transtirretina
IL246141A0 (en) Methods for adhering tissue surfaces and materials and biomedical uses thereof
IL251530B (en) Use of cannabinoids in the treatment of degenerative skeletal muscle diseases
EP3180042C0 (en) COMPOSITE MATERIAL FOR TISSUE RESTORATION
PL3206715T3 (pl) Stosowanie kannabidiolu w leczeniu zespołu stwardnienia guzowatego
IL240727B (en) Peptides and compositions for treatment of joint damage
PT3481846T (pt) 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda
LT3226854T (lt) Aminorūgštimi paremta kompozicija skirta fibroelastino atkūrimui odos jungiamuosiuose audiniuose
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK2945642T3 (da) Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
IL246269B (en) Compositions and methods for treating fatty tissue buildup
EP3528857A4 (en) COMPOSITIONS FOR HAMOSTASIS, REPAIR AND TISSUE RECONSTRUCTION
SI3151853T1 (sl) Dekarboksilaza glutaminske kisline (GAD) za uporabo v zdravljenju avtoimunske bolezni
DK3044229T3 (da) Peptider til anvendelse i behandlingen af oral mucositis
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
IL251345A0 (en) Compositions for use in the treatment of peri-implantitis
PL3145592T3 (pl) Kompozycja do pielęgnacji skóry
IL277377B (en) Prohemostatic proteins for the treatment of bleeding
PL3365068T3 (pl) Kompozycja kosmetyczna do wybielania skóry
CL2015001520A1 (es) Proteina slurp-1 para usarse en el tratamiento de enfermedades oculares
HUE065202T2 (hu) Készítmény bélelváltozások kezelésében való felhasználásra
EP2964330A4 (en) COMPOSITIONS AND METHOD FOR HEARTWEAVER PARAATURE